The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
sana biotechnology announces layoffs and shifts focus to autoimmune diseases
Sana Biotechnology is laying off staff and shifting its focus to B-cell associated autoimmune diseases and Type 2 diabetes, discontinuing its cancer and neurological programs. The company, which has seen its share value plummet over 80% since its IPO, aims to partner on its remaining therapies while prioritizing research that could enhance its value by 2026.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.